1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6616612B354C5212B852584B5002FD3BF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(FIELD+Subject+CONTAINS+%22launch%22)+AND+(%22launch%22)+and+(field+ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&sort=relevance&Start=1&Count=10
18
19OpenForm&Query=(FIELD+Subject+CONTAINS+%22launch%22)+AND+(%22launch%22)+and+(field+ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&sort=relevance&Start=1&Count=10
2034.237.51.35
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 24 Total Hits, Sorted by Relevance.

    |    

Maximizing the Impact of Medical Affairs in Product LaunchDirect access to this research is not included with your membership level.

In the past decade, Medical Affairs has significantly evolved to play a critical role in launch success... (ID POP-311)
Companies Profiled: AbbVie, AcelRx, Alcon Laboratories, Alkermes, more ...

Best Practices and the Role of Medical Affairs in Oncology Launch ExcellenceDirect access to this research is not included with your membership level.

A rapidly changing marketplace, coupled with a restricted promotional environment have pushed the Medical Affairs (MA) function beyond its traditiona... (ID POP-265)
Companies Profiled: Astellas, Bayer, Incyte, Insyght, more ...

Medical Affairs Launch Excellence: Medical Affairs Role at Launch in Medical Device CompaniesDirect access to this research is not included with your membership level.

As a conduit between medical device organizations and key decision makers, the Medical Affairs function plays an important role in key product launch... (ID POP-274)
Companies Profiled: Abbott, Arthur F. Morelli and Associates, Axon Pharma, BARD Medical, more ...

Medical Affairs’ Role in Ensuring Excellence in Product LaunchDirect access to this research is not included with your membership level.

A successful product launch in today’s competitive and regulated marketplace is highly dependent on value-based and science-driven decision making... (ID POP-256)
Companies Profiled: Amgen, Insyght, Astellas, Incyte, more ...

Optimizing Global Brand Website LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

The global launch of a brand website represents a critical point in a new product's entry into the marketplace... (ID PSM-297)
Companies Profiled: Bayer, Novo Nordisk, Sanofi, Abbvie, more ...

Winning Necessary Resources for a Successful Product LaunchDirect access to this research is not included with your membership level.

The objective of this benchmarking study is to help biopharma leaders develop competitive launch and pre-launch activity budgets to ensure successful U... (ID PSM-326)
Companies Profiled: Abbott, AbbVie, Amgen, Astellas, more ...

How Medical Affairs Can Drive a Successful Medical Device Product LaunchDirect access to this research is not included with your membership level.

The gradual shift toward real world evidence in the medical device industry coupled with intense competition and a highly regulated promotional envir... (ID POP-306)
Companies Profiled: Abbott, AcelRx, Alcon, Alcresta Therapeutics, more ...

What it Takes to Successfully Launch an Oncology Product in the U.S. MarketplaceDirect access to this research is not included with your membership level.

Pharmaceutical companies launching an oncology product in the United States often face crowded markets and regulatory constraints... (ID PSM-341)
Companies Profiled: Astellas, Bayer, EMD Serono, Lilly, more ...

Growing Biopharma Digital Marketing Impact: Digitizing Launch, Developing Talent and Optimizing Service AlignmentDirect access to this research is not included with your membership level.

Digital Marketing has transformed the speed with which physicians, patients and other customer groups can be engaged at the moment of launch to rapid... (ID PSM-334)
Companies Profiled: Alkermes, Astellas, Baxter BioScience, Bayer, more ...

Launching A Specialty-Care Blockbuster Franchise in Hepatitis C: How Sovaldi & Harvoni Rewrote New Product Launch HistoryDirect access to this research is not included with your membership level.

The first all-oral HCV medication, Sovaldi went on to become the biggest blockbuster in Pharma history... (ID PSM-322)
Companies Profiled: Gilead Sciences, Merck